AustinPx CSO Dave Miller, PhD, uses a recent BioPharm International conversation to spotlight earlier sponsor engagement, lifecycle-minded IP strategy, and high-science platforms like KinetiSol as pillars of “true co-development.” He positions modern CDMO partnerships as extensions of the sponsor team, from early design decisions through commercialization.
